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Background. Ischemic nephropathy is a common cause of
end-stage renal disease. Exploration of the mechanisms of de-
terioration of renal function is limited due to lack of noninvasive
techniques available to study the single kidney. The Blood Oxy-
gen Level–Dependent (BOLD) MRI method can measure de-
oxyhemoglobin and therefore indirectly estimates renal oxygen
content, but has never been evaluated in renal artery stenosis
(RAS). This study was therefore designed to test if BOLD can
detect the characteristic of renal hypoxia induced by RAS.
Methods. RAS was induced in 8 pigs using an occluder placed
around the right renal artery. Renal blood flow (RBF) was mea-
sured continuously with an ultrasound probe. BOLD signal was
measured bilaterally in the cortex and medulla (as the slope of
the logarithm of MR signal) at baseline and at the lower limit
of RBF autoregulation. The measurements were then repeated
during six sequential graded decreases in RBF (80 to 0% of
baseline) and during recovery.
Results. During the control period, BOLD signals were not
significantly different between the right and the left kidneys.
In the occluded kidney, BOLD signal of the cortex (19.3 ±
1.9/s) and the medulla (17.3 ± 2.0/s) increased during occlu-
sion gradually and significantly (P < 0.0001) to a maximum (at
total occlusion) of 33.8 ± 2.0/s (+79%) and 29.8 ± 2.3/s (+78%),
respectively, and returned to baseline values during recovery.
Conclusion. This study shows that the BOLD technique can
noninvasively detect change in intra-renal oxygenation during
an acute reduction of RBF. This study provides a strong ratio-
nale for developing the BOLD method for the detection and
evaluation of renal hypoxia induced by RAS, which may be
potentially applicable in humans.
The most common form of ischemic nephropathy [1,
2], renal artery stenosis (RAS), has not been sufficiently
characterized as a hypoxic nephropathy. Although it is
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widely accepted that prolonged compromise of renal
blood flow (RBF) produces a loss of renal function, it is
not clear that this dysfunction results from failure of tissue
oxygen delivery, because reduction of RBF can also de-
crease glomerular filtration and filtered sodium load, and
consequently, oxygen consumption [3]. Therefore, until
recently, lack of noninvasive methods to measure intra-
renal oxygen content limited the assessment of hypoxia
in the mechanisms of renal injury in ischemic nephropa-
thy, which is becoming the primary cause for end-stage
renal disease [4, 5].
Blood oxygen level-dependent (BOLD) magnetic res-
onance imaging (MRI) is a noninvasive method capable
of providing regional measurements of oxygen content.
The basic principle of BOLD is that magnetic field pertur-
bations [6] caused by paramagnetic molecules lead to a
loss of phase coherence and therefore signal attenuation
in gradient echo T2∗-weighted sequences. Since deoxy-
hemoglobin (as opposed to oxyhemoglobin) is paramag-
netic, a change in tissue oxygenation would modify tissue
T2∗. Indeed, the method has been shown to be capable
of detecting a change in renal oxygen content during ad-
ministration of diuretics [7, 8], indicating its potential to
detect pathophysiologic changes in renal oxygen content.
Nevertheless, the ability of this method to detect changes
in intra-renal oxygenation has not been tested in RAS.
We hypothesized that the changes in RBF induced by
RAS would modify the renal content of oxygen and there-
fore the BOLD MRI signal. To test this hypothesis, we
measured the changes in renal oxygen content estimated
by BOLD during induced decrements in RBF induced
acutely by progressive renal arterial constriction.
METHODS
Animal preparation
The experimental protocol was approved by the Mayo
Clinic Institutional Animal Care and Use Commit-
tee. Eight domestic (Sus Scrofa) pigs (32 ± 1.4 kg)
were anesthetized (ketamine 0.2 mg/kg/min and xylazine
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0.03 mg/kg/min). A catheter was introduced into the
left external jugular vein for infusion of isotonic saline
(5 mL/min), inulin, para amino hipuric acid (PAH),
and furosemide. A blood sample was drawn for creati-
nine measurement. A catheter was positioned in the left
carotid artery to measure mean arterial pressure (MAP)
and arterial blood oxygen.
The right kidney and renal artery were then isolated
through a median laparotomy. An ultrasound (US) flow
probe adapted for MRI (Transonic, Ithaca, NY, USA),
was placed around the proximal right renal artery. A
pneumatic vascular occluder (4 mm; Harvard Apparatus,
Holliston, MA, USA) was placed around the artery be-
tween the flow probe and the kidney hilus. Ureters were
cannulated for urine collections. Continuous infusion of
inulin and PAH (2% in saline at a rate of 1 mL/min) was
started immediately after collecting a baseline sample of
urine. Additionally, in three pigs, a catheter was also po-
sitioned in the right renal vein to collect blood for renal
vein blood gas measurements.
After surgery, the pig was placed in a specially designed
plexiglass bed for transportation and positioned in the
MRI scanner (Signa Echo Speed; GE Medical Systems,
Milwaukee, WI, USA). The pig was ventilated artificially
with room air. RBF and MAP were recorded continu-
ously with a US flowmeter (T206 Flowmeter, Transonic)
and a pressure transducer, respectively.
Experimental protocol
After hemodynamic stabilization, the baseline BOLD
images were acquired. With an indeflator syringe, the oc-
cluder was then inflated progressively until RBF started
to decrease, and then slightly deflated to restore the basal
RBF value, which is the lower limit of RBF autoreg-
ulation. After a 15-minute stabilization, BOLD images
were acquired. Then a progressive step-wise RAS was
performed by manually inflating the vascular occluder to
decrease RBF to 80%, 60%, 40%, 20%, 10%, and 0%
of baseline value, defined as “S80,” “S60,” etc. Follow-
ing each step, a 15-minute stabilization period was al-
lowed and BOLD images acquired. Then, the occluder
was released. BOLD images were acquired during recov-
ery after 5, 10, and 15 minutes. Following this, to check
the response of the kidney to a well-known stimulus,
furosemide (20 mg, intravenous) was given as a bolus.
The last BOLD images were acquired 15 minutes later.
Single kidney inulin and PAH clearances were per-
formed by collecting urine from each ureter every
15 minutes and blood (10 mL) from central catheter (im-
mediately before BOLD measurement). In three pigs, ar-
terial and right renal vein samplings were performed to
measure renal oxygen consumption immediately before
BOLD measurement.
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Fig. 1. Logarithm of MR signal as a function of echo time. A represen-
tative BOLD signal measurement (/s) in both kidneys of a pig at total
occlusion of one renal artery. Calculated slope are given in parentheses.
Bold imaging
The principle of the BOLD method is that param-
agnetic molecules induce magnetic field perturbations.
These perturbations lead to a faster signal attenuation in
gradient echo T2∗-weighted sequences. In the blood, oxy-
hemoglobin is diamagnetic and its concentration has no
effect on T2∗, but deoxyhemoglobin is paramagnetic and
will decrease tissue T2∗. Therefore, when the echo time
of the gradient echo MRI acquisition increases, the MRI
signal attenuation increases with increased concentration
of deoxyhemoglobin. Acquisition of MRI images with in-
creasing echo times then allows computation of their re-
gression with the logarithm of the signal [7]. This slope is
an estimate of the relaxivity R2∗, defined as 1/T2∗, related
to the concentration of deoxyhemoglobin and therefore
to blood and tissue oxygen content.
Three transaxial slices over the two kidneys were se-
lected using a scout acquisition. A gradient echo se-
quence was used to acquire the T2∗-weighted images of
the kidneys at end expiration. TR (repetition time) was
70 milliseconds, and TE (echo time) increased from 7 to
56.6 milliseconds, with a 3.3-millisecond step (a total of
16 images over 15 seconds). For data analysis, regions of
interest were traced in the cortex and medulla manually,
on the 7-millisecond echo time image that gave the best
anatomic details. For each echo time, the software au-
tomatically computed the average of MR signals within
each regions of interest. The BOLD signal, as character-
ized by the relaxivity R2∗, was then measured as the slope
of the logarithm of MR signals as a function of the echo
time (Fig. 1).
Renal hemodynamics and function
Plasma and urine inulin [9] and PAH [10] concentration
were measured using a standard colorimetric method,
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Table 1. R2∗ BOLD-derived measurements (mean ± SEM units of 1/seconds) with percentage of variation versus baseline in parenthesis
Recovery
Complete after
Baseline obstruction 15 minutes Furosemide
Occluded cortex (/s) 19.3 ± 1.9 33.8 ± 2.0 (+79%)a 19.2 ± 1.7 (+0.3%) 18.1 ± 1.6 (−5.5%)d
Occluded medulla (/s) 17.3 ± 2.0 29.8 ± 2.3 (+78%)a,e 17.7 ± 2.6 (+2.8%) 15.8 ± 2.1 (−8.8%)d
Contralateral cortex (/s) 16.4 ± 0.8 17.8 ± 1.1 (+8.6%) 18.7 ± 1.2 (+13%)b,c 16.2 ± 1.0 (−1.7%)d
Contralateral medulla (/s) 17.1 ± 1.5 18.2 ± 1.9 (+5.9%) 19.0 ± 2.7 (+10%) 15.0 ± 2.2 (−14%)d
aP < 0.0001 vs. BL.
bP < 0.05 vs. BL.
cP < 0.05 vs. complete obstruction.
dP < 0.05 vs. recovery.
eP < 0.05 occluded vs. contralateral kidney (factorial ANOVA).
and their clearances were calculated as U∗V/P, where U is
the urine concentration, V the volume of urine collected
during the clearance period from each kidney, and P is
the plasma concentration. Glomerular flow rate (GFR)
was estimated by inulin clearance. Effective renal plasma
flow (ERPF) was estimated as the product of PAH clear-
ance by 0.9 for extraction correction. Plasma (PNa) and
urine (UNa) sodium concentration were measured with a
flame photometer (IL943; Instrumentation Laboratory,
Monza, Italy). The amount of sodium reabsorbed was
calculated as PNa × GFR − UNa × V.
Oxygen consumption (OC, Eq. 1) was calculated as the
arteriovenous difference in oxygen concentration [11],
where Hb is the blood hemoglobin concentration, SaO2 is
hemoglobin saturation in arterial blood, PaO2 is oxygen
partial pressure in arterial blood, SrvO2 is hemoglobin
saturation in renal vein blood, PrvO2 is oxygen partial
pressure in renal vein blood, RBF is measured by the
ultrasound flow probe, and UF is the urine flow.
OC = ((1.39 ∗ Hb ∗ SaO2) + (0.03 ∗ PaO2)) ∗ RBF
− ((1.39 ∗ Hb ∗ SrvO2) + (0.03 ∗ PrvO2))
∗ (RBF − UF) (Eq. 1)
Statistical analysis
Repeated-measures analysis of variance (R-ANOVA)
with Fisher post-hoc test was used to test the change in
BOLD signal. In each intervention, the BOLD signal was
compared with baseline with a paired t test. Differences
between parameters measured on the occluded and con-
tralateral kidneys were tested with an unpaired t test, and
with a factorial ANOVA (F-ANOVA) for parameters dis-
tinguishing the cortex and medulla. Results are reported
as mean ± SEM.
RESULTS
Bold measurements
At baseline, the BOLD-derived R2∗ values were not
significantly different (F-ANOVA, P = 0.63) in the two
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Fig. 2. R2∗ BOLD-derived signal measurement (1/sec) at baseline
(BL), at the lower limit of RBF autoregulation (AR), with RBF at 80%
to 0% RBF at baseline (S80 to S0), after 5, 10, and 15 minutes of recov-
ery (R5 to R15), and after furosemide injection (FR). Obstructed cortex
(OC), ; contralateral cortex (CLC), ; obstructed medulla (OM), ;
contralateral medulla (CLM), . ∗P < 0.05 vs. baseline; P < 0.05 vs.
recovery.
cortices and medullas (Table 1). R2∗ of the obstructed
(right) kidney started to increase when the decrease
of RBF reached 60% of baseline, and it continued to
increase from there on each gradual flow reduction
(R-ANOVA, P < 0.0001) (Fig. 2). The changes in R2∗
were significantly different (R-ANOVA, P = 0.018) be-
tween the obstructed and contralateral cortex (P < 0.008)
and tended to be different between the two renal medul-
las (P < 0.063). In the contralateral cortex, there was
a small but significant increase in R2∗ (R-ANOVA,
P < 0.0001) from S60 to S20. From S40 to S0, R2∗ was
significantly different between the obstructed and non-
obstructed cortex.
During recovery (Table 1), R2∗ returned quickly to
baseline values without statistical differences between
obstructed and non-obstructed kidneys (F-ANOVA,
P = 0.95, R15). After furosemide injection (Table 1), R2∗
measured in all regions decreased significantly (P < 0.03)
as compared with R15.
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Table 2. Renal hemodynamics and function at baseline
(mean ± SEM)
Obstructed Contralateral
kidney kidney
Urine flow mL/min 3.31 ± 0.5 3.66 ± 0.5
Glomerular flow rate mL/min 28.2 ± 2.6 30.3 ± 2.9
Effective renal plasma flow mL/min 68.9 ± 5.3 76.2 ± 6.6
Tubular sodium reabsorption mmol/min 3475 ± 383 3703 ± 406
Renal hemodynamics and function
Single-kidney urine flows (UV), GFR, ERPF, tubular
sodium reabsorption, and fractional sodium reabsorption
were not significantly different at baseline between the
two kidneys (Table 2). The occluded kidney showed a
significant decrease in UV from S80 to S0 (R-ANOVA,
P < 0.0001, Fig. 3A), while the contralateral showed only
a transient decrease (R-ANOVA, P = 0.004) at S40. Both
returned to baseline values during recovery, but signifi-
cantly increased after furosemide injection (P < 0.01).
GFR, ERPF, and tubular sodium reabsorption de-
creased significantly in the occluded kidney (R-ANOVA,
P < 0.0001), with significant changes versus baseline from
S80 to S0 (S60 for ERPF), but remained unchanged in
the non-obstructed kidney (Fig. 3 B to D). GFR was
significantly decreased in the obstructed kidney (P =
0.03) after furosemide injection. During recovery, ERPF
(Fig. 3C) was significantly increased in the obstructed kid-
ney compared with baseline (reactive hyperemia). Frac-
tional sodium reabsorption increased progressively from
91.9 ± 2.7% to 96.6 ± 3.1% at complete obstruction in
the obstructed kidney. However, these changes did not
reach statistical significance in either kidney. Fractional
sodium reabsorption significantly decreased in both kid-
neys after furosemide injection. Mean arterial pressure
was not significantly changed during the procedure.
In the obstructed kidney, basal renal oxygen con-
sumption was 3.98 ± 0.20 mLO2/min (Fig. 3E). Oxygen
consumption decreased significantly during renal artery
constriction (R-ANOVA, P < 0.0001) and changes of
oxygen consumption compared with baseline were sig-
nificant from S80 to S0. It must be pointed out that the
null oxygen consumption calculated when the RBF is
stopped is the mathematical consequence of the null RBF
itself. This is a minor limitation of this indirect method
of calculating tissue oxygen consumption, not affecting
calculation when blood flow is not 0. Oxygen con-
sumption returned to baseline during recovery and was
unchanged after furosemide injection. There was no sig-
nificant change in arterial blood oxygen content during
the obstruction periods (R-ANOVA, P = 0.78)
No anatomic abnormality of the kidney and its vascu-
lature was observed during surgery, and baseline creati-
nine appeared normal (102 ± 6 lmol/L). In the obstructed
kidney, basal RBF measured by PAH clearances (115 ±
9 mL/min) was similar to the actual basal RBF measured
with the ultrasound probe (102 ± 10 mL/min).
DISCUSSION
This study shows, for the first time, that the BOLD-
derived R2∗ relaxivity signal was significantly increased
in the renal cortex and medulla during acute reduction of
renal blood flow induced by renal artery stenosis.
Renal oxygen content measurement is challenging
because of the complexity of renal architecture. The
renal cortex and medulla have different vasculature,
function, and metabolism, resulting in an intra-renal
complex pattern of oxygen distribution. Because of
this intra-renal spatial variability, tomographic measure-
ments have a unique potential to provide sensitive as-
sessments of regional oxygenation. Indeed, BOLD is the
only technique currently available that allows noninva-
sive measurement of oxygen content in the kidney.
We observed that BOLD signals were significantly en-
hanced by the constriction of the renal artery. These
results strongly support our initial assumption that the
reduction of RBF induced a progressive hypoxia and a
resultant increased deoxyhemoglobin concentration de-
tectable by BOLD. In our study, the R2∗ relaxivity sig-
nal increased continuously and progressively in parallel
with the decrease in RBF, suggesting evolving hypoxia in
both the medulla and cortex. This is an important find-
ing because it has been hypothesized that a decrease of
RBF does not lead to renal hypoxia as a consequence
of a simultaneous decrease in oxygen consumption in-
duced by a fall in tubular sodium reabsorption [12]. This
assumption was suggested by the observation showing
a significantly higher oxygen saturation in the venous
blood from human RAS kidney compared with the con-
tralateral kidney [13]. Nevertheless, evaluation of renal
oxygen content by measuring renal vein oxygen concen-
tration [14] is further complicated due to the existence
of intra-renal oxygen shunts [15, 16], not only in the
medulla but also in cortex (between interlobular arter-
ies and veins). In contrast to renal vein measurements,
BOLD provides regional measurements directly derived
from renal parenchyma. Renal oxygen content as mea-
sured by BOLD decreased as soon as RBF was dimin-
ished from baseline (significantly over a 60% reduction
in blood flow), even in the presence of a significant and
rapid decrease in renal oxygen consumption. Our find-
ings are consistent with the fact that both the medulla
and cortex can operate at low oxygen pressure, even if
oxygen levels are high in the renal vein [17].
Another interesting finding in this study is that dur-
ing a decrease in RBF by renal artery constriction, the
oxygen content as measured by the BOLD method was
consistently lower in the cortex than in the medulla. No
data are currently available to show direct measurement
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of tissue oxygen in the kidney during RAS. Neverthe-
less, using silastic tonometers in a hemorrhage model in
dogs, Nelimarkka et al [18] reported that over a 40%
blood volume hemorrhage of the PO2 in the cortex was
less than in the medulla. Brezis et al [19], using oxygen
microelectrodes in rats, also reported that during renal
hypoperfusion the cortical PO2 decreased below the PO2
in the medulla, possibly due to relative preservation of
medullary blood flow through juxtamedullary nephrons.
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Fig. 3. Mean ± SEM of (A) urine flow (mL/min), (B) glomerular flow
rate (GFR, mL/min), (C) effective renal plasma flow (ERPF, mL/min);
(D) tubular sodium reabsorption (mmol/min), and (E) oxygen con-
sumption (mLO2/min). Interventions are baseline (BL), RBF in the
lower limit of RBF autoregulation (AR), RBF at 80% to 0% RBF at
baseline (S80 to S0), after 5, 10, and 15 minutes of recovery (R5 to R15),
and after furosemide injection (FR). Right obstructed (Obs) kidney, ,
left intact contralateral (CL) kidney, . ∗P < 0.05 vs. baseline.
Therefore, our findings are consistent with those previous
reports. It must be emphasized that this redistribution of
oxygen content between cortex and medulla may indicate
a significant intracortical hypoxia in RAS.
This study demonstrates that the BOLD method has
the ability to measure oxygen content dynamically. Only
five minutes after the release of the constriction, BOLD
signal returned to values identical to the baseline val-
ues, and stayed unchanged for the remaining 15 minutes.
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BOLD signal decreased significantly after furosemide in-
jection. This result is consistent with the significant de-
crease in fractional sodium reabsorption observed in our
study. With BOLD, Prasad et al [7] showed in humans
that furosemide increased oxygen content in the medulla
and cortex, by decreasing sodium reabsorption in the
thick ascending limb. Epstein et al [8] later showed that
furosemide increased oxygen content in the medulla and
cortex in young people without chronic renal failure, but
not in older patients with mild chronic failure. This group
showed that BOLD was enhanced by iodine contrast me-
dia and nonsteroidal anti-inflammatory agents (NSAI)
[20].
The measurements of oxygen content in this study were
not validated against a reference measure such as pO2
microelectrodes, since these would not be feasible in the
electromagnetic environment of the MRI scanner. Then,
it could be hypothesized that R2∗ may be modified di-
rectly by renal blood flow without change in renal oxygen
content. Nevertheless, Prasad et al [7] demonstrated that
R2∗ was decreased by the injection of furosemide, with-
out a change in renal blood flow. Our results obtained
after furosemide injection lead to the same conclusion.
Accordingly, Reis et al [21] demonstrated that R2∗ was
increased by low PO2 breathing, without a change in re-
nal blood flow. Those two different type of experiments
demonstrated that R2∗ BOLD-derived measurement is
not dependent on renal blood flow, per se. It then becomes
a very reasonable assumption that the increase observed
in R2∗ in this study represents a decrease in oxygen con-
tent, as an indirect consequence of the gradual decrease
in blood flow, and not the decrease of the blood flow itself.
Furthermore, the purpose of the study was to determine
if the BOLD method could detect changes induced by
a decrease in RBF. Our results strongly support this as-
sumption. Without actual calibration, absolute quantifi-
cation of the R2∗ BOLD-derived signal remains difficult
[7], because it depends on parameters set during scout ac-
quisition. However, the BOLD measurement is derived
from a slope derived from repeated MR signals, and no
longer from the scout parameters; hence, results can be
given in absolute values. In our study, BOLD signal at
baseline tended to be higher than that measured in hu-
mans by Prasad et al [7, 8].
Unexpectedly, there was no significant difference in
BOLD-derived R2∗ value at baseline between cortex and
medulla, in both obstructed and non-obstructed kidneys.
Our results contrast with the findings of other investi-
gators showing that BOLD repeatedly detected lower
oxygen content in the medulla in different studies in hu-
mans [7, 8, 22, 23], results that were in agreement with
measurements performed with microelectrodes in exper-
imental animals. Therefore, our findings are most likely
not related to the BOLD methodology, per se, but to
other experimental factors. For example, it could have
been related to the surgery performed on the renal artery
to gradually decrease the renal blood flow. This surgery
could have decreased renal blood flow in the obstructed
kidney, with a consequent increase in R2∗ at baseline in
the cortex, compared to the medulla. Furthermore, open
surgery might have changed regional blood flow, there-
fore decreasing renal blood flow in both kidneys, leading
to the absence of oxygen content difference in the cortex
and medulla. Second, it may be an effect of hemodynamic
changes by anesthesia. Prasad et al [20], who published all
the studies in humans, did not detect a significant differ-
ence in R2∗ between cortex and medulla in anesthetized
rats, using identical methods to the human studies. Third,
it could be related to the animal species itself, as pigs
appear to have a higher fractional medullary blood flow,
as demonstrated by Lerman et al [24–26]. Then it can
be hypothesized that this higher blood flow could po-
tentially reduce the degree of relative ischemia as com-
pared with the cortex in pigs. Finally, it must be pointed
out that Epstein et al found differences in humans who
fasted overnight. They showed that an increase in urine
flow due to water intake almost abolished the difference
in R2∗ between cortex and medulla. Therefore, it can be
hypothesized that a higher hydration level, mandatory
for performing clearances, could explain our findings.
In order to test these hypothesis, we measured R2∗
in an additional set of 4 animals, without surgery, under
lighter anesthesia and using minimal injection of fluid dur-
ing anesthesia administration (30 instead of 200 mL/hr).
Interestingly, the relationship between the values of the
cortex and medulla remained similar to those surgically
in the current study; in these observations, cortical values
were slightly lower than those in the medulla, but this
has not reached statistical significance. Therefore, base-
line R2∗ values appear not to be markedly changed by the
surgical intervention, anesthetic delivery rate, and hydra-
tion level.
Therefore, we assume that our findings are most likely
related to relatively high medullary perfusion with re-
duced difference in oxygen content in pigs that undergo
light anesthesia. In fact, this situation may not change
by further surgical intervention. Nevertheless, despite a
potential limit of our model, these findings in pigs do
not compromise the validity of the conclusion of this
study (i.e., demonstrating a marked increase in R2∗ when
blood flow has been dropped about 60% of hour values
recorded in the basal period).
As demonstrated by Ries et al [21], a reduction of blood
oxygen content increases R2∗ tissue values independently
of renal hemodynamics. Blood hemoglobin concentra-
tion may also affect R2∗ values. Therefore, oxygen sat-
uration and hemoglobin concentration may have to be
taken into account in studies involving patients.
It is worth emphasizing that the BOLD method could
have a wide and important clinical application in ischemic
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nephropathy, recognized as the second most frequent
cause for end-stage renal disease [27]. Therefore, pre-
venting the decline of GFR by restoring RBF with revas-
cularization methods could be a major therapeutic tar-
get. However, the outcome of revascularization methods
shows that in a minority of patients, kidney function is
improved, while in most of the patients renal function
is unchanged, and that a non-negligible number of pa-
tients will lose renal function [1, 28]. Those relatively
poor results may be the consequences of the invasive-
ness of revascularization and the absence of a reliable
predictive test to distinguish lesions of ischemia caused
by RAS versus nephrosclerosis [29]. The development of
a new functional tool is therefore in dire need and may in-
crease the accuracy of revascularization assessment. The
addition of a functional test has been recently shown to
increase the accuracy of renal evaluation in RAS [30].
CONCLUSION
The BOLD method is noninvasive, is fully available
in most of the clinical MRI scanners, can be performed
in a single breath hold, in conjunction with MR angiog-
raphy, and does not require nephrotoxic contrast media.
New functional tools, such as BOLD, capable of detecting
ischemia and characterizing patterns of intra-renal oxy-
gen levels, may assist in identifying patients that would
be more likely to benefit from therapeutic procedures.
Future studies in chronic animal models and in humans
would be needed to establish the utility of this method
and determine a threshold BOLD value that would indi-
cate a significant hypoxia in the kidney.
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